Displaying drugs 12401 - 12425 of 12696 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Vernakalant | 349.471 C20H31NO4 |  | An antiarrhythmic medication used to treat patients with atrial fibrillation. | Antiarrhythmic agents / Antiarrhythmics, Class III / Benzene Derivatives / Cardiac Therapy / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Ethers / Methyl Ethers / Phenols / Phenyl Ethers / Potential QTc-Prolonging Agents / QTc Prolonging Agents |
| Verpacamide A | 253.3009 C11H19N5O2 |  | Not Available | Not Available |
| Verteporfin | Not Available |  | A benzoporphyrin derivative used to treat pathological myopia, ocular histoplasmosis, and choroidal neovascularization in macular degeneration. | Antineovascularisation Agents |
| Verubecestat | 409.41 C17H17F2N5O3S |  | Verubecestat is under investigation for the treatment of Alzheimer's Disease, Prodromal Alzheimer's disease, and Amnestic Mild Cognitive Impairment. Verubecestat is Merck’s investigational oral β-site amyloid precursor protein cleaving enzyme (BACE1... | Sulfur Compounds / Thiazines |
| Verubulin | 279.343 C17H17N3O |  | Investigated for use/treatment in brain cancer, lung cancer, melanoma, and solid tumors. | Heterocyclic Compounds, Fused-Ring |
| Verucerfont | 406.49 C22H26N6O2 |  | Verucerfont has been used in trials studying the treatment of Congenital Adrenal Hyperplasia. | Receptors, Corticotropin-Releasing Hormone, antagonists & inhibitors |
| Vesatolimod | 410.522 C22H30N6O2 |  | Vesatolimod has been used in trials studying the treatment of Hepatitis B and Chronic Hepatitis B. | Antiviral Agents / Toll-Like Receptor 7, agonists |
| Vesnarinone | 395.4516 C22H25N3O4 |  | Vesnarinone has been used in trials studying the treatment of HIV Infections and Sarcoma, Kaposi. | Adjuvants, Immunologic / Antineoplastic Agents / Cardiotonic Agents / Phosphodiesterase Inhibitors |
| Vestipitant | 491.454 C23H24F7N3O |  | Vestipitant has been investigated for the treatment of Tinnitus. | Neurokinin-1 Receptor Antagonists |
| VGV-1 | Not Available |  | Investigated for use/treatment in HIV infection. | Not Available |
| Vibegron | 444.535 C26H28N4O3 |  | A beta-3 adrenergic agonist the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults. | Adrenergic Agonists / Adrenergic beta-3 Receptor Agonists / Adrenergic beta-Agonists / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs for Urinary Frequency and Incontinence / Genito Urinary System and Sex Hormones / Genitourinary Smooth Muscle Relaxants / P-glycoprotein substrates / Pyrimidines / Selective Beta 3-adrenergic Agonists / Urologicals |
| Vibriolysin | Not Available |  | Investigated for use/treatment in burns and burn infections. | Not Available |
| Vicagrel | 379.86 C18H18ClNO4S |  | Vicagrel is under investigation in clinical trial NCT03599284 (The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel). | Antiplatelet agents |
| Vicriviroc | 533.6288 C28H38F3N5O2 |  | Investigated for use/treatment in HIV infection and viral infection. | Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Substrates |
| Vidarabine | 267.2413 C10H13N5O4 |  | An antiviral agent used to treat various viral infections. | Antiviral Agents / Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors |
| Vidofludimus | 355.365 C20H18FNO4 |  | Vidofludimus is under investigation in clinical trial NCT03722576 (Vidofludimus Calcium for Primary Sclerosing Cholangitis). | Acids, Acyclic / Benzene Derivatives |
| Vidupiprant | 609.49 C28H27Cl2FN2O6S |  | Vidupiprant has been used in trials studying the treatment and basic science of Asthma. | Acids, Carbocyclic / Amides / Sulfones / Sulfur Compounds |
| Vigabatrin | 129.157 C6H11NO2 |  | An irreversible GABA transaminase inhibitor used as an adjunct therapy to treat refractory complex partial seizures in patients ≥2 years unresponsive to alternatives. May also be used as monotherapy to treat infantile spasms in infants 1 month to 2 years. | Fatty Acid Derivatives |
| Vilanterol | 486.43 C24H33Cl2NO5 |  | A long-acting beta2-adrenergic agonist used in combination with other bronchodilators for the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. | Agents producing tachycardia / Agents that produce hypertension |
| Vilaprisan | 544.58 C27H29F5O4S |  | Vilaprisan has been used in trials studying the treatment of Leiomyoma and Clinical Trial, Phase I. | Fused-Ring Compounds |
| Vilazodone | 441.5249 C26H27N5O2 |  | An antidepressant agent used for the treatment of major depressive disorder that targets the 5-HT transporter and 5-HT1A receptors. | Agents that produce hypertension |
| Vildagliptin | 303.3993 C17H25N3O2 |  | A once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. | DPP-IV Inhibitors |
| Viloxazine | 237.299 C13H19NO3 |  | A selective norepinephrine reuptake inhibitor indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults in children. | Adrenergic Uptake Inhibitors / Antidepressive Agents, Second-Generation / Morpholines / Norepinephrine Reuptake Inhibitor |
| Viminol | 362.94 C21H31ClN2O |  | An opioid analgesic indicated in the treatment of pain. | Alcohols / Amines / Amino Alcohols / Analgesics / Nervous System |
| Vimseltinib | 431.5 C23H25N7O2 |  | Not Annotated | Not Annotated |
Displaying drugs 12401 - 12425 of 12696 in total